• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgG4亚类谷氨酸脱羧酶抗体(GADA)与1型糖尿病发病风险降低以及GADA阳性妊娠糖尿病患者C肽水平升高有关。

IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes.

作者信息

Dereke Jonatan, Nilsson Charlotta, Strevens Helena, Landin-Olsson Mona, Hillman Magnus

机构信息

Lund University, Department of Clinical Sciences, Diabetes Research Laboratory, Lund, Sweden.

Lund University, Department of Clinical Sciences, Diabetes Research Laboratory, Lund, Sweden; Helsingborg Hospital, Department of Pediatrics, Helsingborg, Sweden.

出版信息

Clin Immunol. 2016 Jan;162:45-8. doi: 10.1016/j.clim.2015.11.001. Epub 2015 Nov 5.

DOI:10.1016/j.clim.2015.11.001
PMID:26548838
Abstract

Some women with gestational diabetes (GDM) present with autoantibodies associated with type 1 diabetes. These are usually directed against glutamic acid decarboxylase (GADA) and suggested to predict development of type 1 diabetes. The primary aim of this study was to investigate if GADA IgG subclasses at onset of GDM could assist in predicting postpartum development. Of 1225 women diagnosed with first-time GDM only 51 were GADA-positive. Total GADA was determined using ELISA. GADA subclasses were determined with radioimmunoassay. Approximately 25% of GADA-positive women developed type 1 diabetes postpartum. Titers of total GADA were higher in women that developed type 1 diabetes (142.1 vs 74.2u/mL; p=0.04) and they also had lower titers of GADA IgG4 (index=0.01 vs 0.04; p=0.03). In conclusion we found that that women with high titers of total GADA but low titers of GADA IgG4 were more prone to develop type 1 diabetes postpartum.

摘要

一些患有妊娠期糖尿病(GDM)的女性体内存在与1型糖尿病相关的自身抗体。这些抗体通常针对谷氨酸脱羧酶(GADA),并被认为可预测1型糖尿病的发展。本研究的主要目的是调查GDM发病时的GADA IgG亚类是否有助于预测产后病情发展。在1225名首次诊断为GDM的女性中,只有51名GADA呈阳性。采用酶联免疫吸附测定法(ELISA)测定总GADA。用放射免疫测定法测定GADA亚类。约25%的GADA阳性女性产后发展为1型糖尿病。发展为1型糖尿病的女性总GADA滴度更高(142.1对74.2u/mL;p=0.04),且她们的GADA IgG4滴度也更低(指数=0.01对0.04;p=0.03)。总之,我们发现总GADA滴度高但GADA IgG4滴度低的女性产后更易发展为1型糖尿病。

相似文献

1
IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes.IgG4亚类谷氨酸脱羧酶抗体(GADA)与1型糖尿病发病风险降低以及GADA阳性妊娠糖尿病患者C肽水平升高有关。
Clin Immunol. 2016 Jan;162:45-8. doi: 10.1016/j.clim.2015.11.001. Epub 2015 Nov 5.
2
Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes.妊娠期糖尿病患者对谷氨酸脱羧酶和胰岛素的免疫反应。
Clin Exp Immunol. 2004 Feb;135(2):318-21. doi: 10.1111/j.1365-2249.2004.02355.x.
3
The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy.韩国妊娠期糖尿病女性中GAD抗体的患病率及其孕期和产后的临床特征。
Diabetes Metab Res Rev. 2009 May;25(4):329-34. doi: 10.1002/dmrr.963.
4
HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitus.HLA-DQB1 基因型与胰岛细胞自身抗体 GAD65 和 IA-2 与妊娠糖尿病妇女产后糖尿病的发展的关系。
Diabetes Res Clin Pract. 2012 Feb;95(2):260-4. doi: 10.1016/j.diabres.2011.10.037. Epub 2011 Nov 21.
5
The prevalence and predictive value of the SLC30A8 R325W polymorphism and zinc transporter 8 autoantibodies in the development of GDM and postpartum type 1 diabetes.溶质载体家族30成员8基因(SLC30A8)R325W多态性及锌转运体8自身抗体在妊娠期糖尿病(GDM)和产后1型糖尿病发生中的患病率及预测价值
Endocrine. 2016 Sep;53(3):740-6. doi: 10.1007/s12020-016-0932-7. Epub 2016 Mar 22.
6
The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.在临床发病后长达3年的时间里,成人迟发性1型糖尿病与成人隐匿性自身免疫性糖尿病(LADA)的谷氨酸脱羧酶65免疫球蛋白G亚类谱存在差异。
Clin Exp Immunol. 2009 Aug;157(2):255-60. doi: 10.1111/j.1365-2249.2009.03939.x.
7
IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.谷氨酸脱羧酶抗体的IgG4亚类在成人隐匿性自身免疫性糖尿病中比在1型糖尿病中更常见。
Diabetologia. 2004 Nov;47(11):1984-9. doi: 10.1007/s00125-004-1558-5. Epub 2004 Nov 24.
8
Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.人类白细胞抗原II类分型对妊娠期糖尿病女性产后胰岛自身抗体产生及胰岛素依赖型糖尿病发生的预测价值
J Clin Endocrinol Metab. 1999 Jul;84(7):2342-8. doi: 10.1210/jcem.84.7.5813.
9
[Identification of the two subtypes of latent autoimmune diabetes in adults by glutamic acid decarboxylase 65 antibody titers].[通过谷氨酸脱羧酶65抗体滴度鉴定成人隐匿性自身免疫性糖尿病的两种亚型]
Zhonghua Nei Ke Za Zhi. 2003 Jan;42(1):7-10.
10
Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.韩国谷氨酸脱羧酶抗体阳性的非肥胖2型糖尿病患者的临床和生化特征
Metabolism. 2006 Aug;55(8):1107-12. doi: 10.1016/j.metabol.2006.04.006.

引用本文的文献

1
Autoantibodies predict type 1 diabetes after gestational diabetes - a 23-year cohort study.自身抗体可预测妊娠糖尿病后 1 型糖尿病——一项 23 年队列研究。
Front Endocrinol (Lausanne). 2023 Dec 20;14:1286375. doi: 10.3389/fendo.2023.1286375. eCollection 2023.
2
Association of single nucleotide polymorphisms with insulin secretion, insulin sensitivity, and diabetes in women with a history of gestational diabetes mellitus.与胰岛素分泌、胰岛素敏感性和糖尿病相关的单核苷酸多态性与有妊娠期糖尿病病史的女性。
BMC Med Genomics. 2021 Nov 20;14(1):274. doi: 10.1186/s12920-021-01123-6.
3
Increase in Peripheral Blood Intermediate Monocytes is Associated with the Development of Recent-Onset Type 1 Diabetes Mellitus in Children.
外周血中间单核细胞增多与儿童新发1型糖尿病的发生相关。
Int J Biol Sci. 2017 Feb 5;13(2):209-218. doi: 10.7150/ijbs.15659. eCollection 2017.